Ambarella Inc: Form 10-K for the period ended Jan 31, 2023
Filed with the SEC on Mar 31, 2023 and accepted by EDGAR at Mar 31, 2023, 14:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-01-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-02-01 to 2023-01-31 | $337.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-02-01 to 2023-01-31 | $128.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2022-02-01 to 2023-01-31 | $208.9m | us-gaap:GrossProfit |
| Research and development | 12 months2022-02-01 to 2023-01-31 | $204.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-02-01 to 2023-01-31 | $78.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-02-01 to 2023-01-31 | −$74.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2022-02-01 to 2023-01-31 | −$5.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-02-01 to 2023-01-31 | −$65.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-02-01 to 2023-01-31 | −$1.70 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-02-01 to 2023-01-31 | −$1.70 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-02-01 to 2023-01-31 | 38,363,638 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-02-01 to 2023-01-31 | $44.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-02-01 to 2023-01-31 | $15.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 12 months2022-02-01 to 2023-01-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-01-31 | $113.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-01-31 | $304.6m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-01-31 | $710.2m | us-gaap:Assets |
| Current liabilities | At period end2023-01-31 | $83.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-01-31 | $104.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-01-31 | $606.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-011305. Last ingested by Listed: Oct 30, 2026, 13:39 ET. Listed shows no prices and gives no investment advice.